Abstract
Cannabigerol (CBG) is a minor, non-psychoactive cannabinoid typically extracted from the plant Cannabis sativa (C. sativa). Utilizing our novel yeast fermentation technology platform, minor cannabinoids such as CBG can be produced in a more sustainable, cost-effective, and timely process as compared to plant-based production. Our aim was to characterize and compare the in vitro activity profile of CBG and the more widely studied Cannabidiol (CBD) in skin and be the first group to test CBG clinically on human skin.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
